← Back to headlines

COYA 302 slows disease progression, lowers biomarkers: Trial

This story is reported by ALS News Today. Read what other outlets are saying below, then open the original report for full details.

COYA 302 slows disease progression, lowers biomarkers: Trial · NabkaNews